- Home
- XIFR vs XERS Comparison
XIFR vs XERS Comparison
Compare XIFR & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XIFR
- XERS
- Stock Information
- Founded
- XIFR 2014
- XERS 2005
- Country
- XIFR United States
- XERS United States
- Employees
- XIFR N/A
- XERS N/A
- Industry
- XIFR
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- XIFR
- XERS Health Care
- Exchange
- XIFR NYSE
- XERS Nasdaq
- Market Cap
- XIFR 815.0M
- XERS 752.7M
- IPO Year
- XIFR N/A
- XERS 2018
- Fundamental
- Price
- XIFR $9.37
- XERS $5.11
- Analyst Decision
- XIFR Hold
- XERS Strong Buy
- Analyst Count
- XIFR 4
- XERS 6
- Target Price
- XIFR $10.75
- XERS $6.25
- AVG Volume (30 Days)
- XIFR 1.0M
- XERS 2.0M
- Earning Date
- XIFR 07-23-2025
- XERS 08-07-2025
- Dividend Yield
- XIFR 19.36%
- XERS N/A
- EPS Growth
- XIFR N/A
- XERS N/A
- EPS
- XIFR N/A
- XERS N/A
- Revenue
- XIFR $1,255,000,000.00
- XERS $222,551,000.00
- Revenue This Year
- XIFR $11.14
- XERS $35.03
- Revenue Next Year
- XIFR $2.34
- XERS $18.31
- P/E Ratio
- XIFR N/A
- XERS N/A
- Revenue Growth
- XIFR 15.14
- XERS 29.88
- 52 Week Low
- XIFR $7.53
- XERS $2.10
- 52 Week High
- XIFR $29.03
- XERS $6.07
- Technical
- Relative Strength Index (RSI)
- XIFR N/A
- XERS 61.48
- Support Level
- XIFR N/A
- XERS $4.62
- Resistance Level
- XIFR N/A
- XERS $5.39
- Average True Range (ATR)
- XIFR 0.00
- XERS 0.21
- MACD
- XIFR 0.00
- XERS 0.07
- Stochastic Oscillator
- XIFR 0.00
- XERS 71.72
About XIFR XPLR INFRASTRUCTURE LP
XPLR Infrastructure LP is formed to acquire, manage, and own contracted clean energy projects. It owns interests in wind and solar projects in North America, as well as natural gas infrastructure assets in Texas. Renewable energy assets consist of wind, solar, and solar-plus-storage projects and a stand-alone battery storage project, as well as contracted natural gas pipeline assets. Renewable energy sales generate maximum revenue for the company.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).